NEWS COMMENTARY

Digital therapeutic outperforms standard physiotherapy in clinical trial for back pain treatment in 40-patient pilot study

Published:
May 09, 2019
Coverage:
Digital Transformation More...
Activities:
Claims
by Danielle Bradnan
Very important

The digital therapeutic, developed by Kaia Health, is an mHealth app that teaches patients specific physical therapy treatment exercises in order to treat pain. The app, which directly replaces an in-person physician, is part of a growing trend in the healthcare space where digital therapeutics are increasingly approved by regulatory bodies to replace traditional modes of care, such as a specialist (Pear Therapeutics' reSET) or a pharmaceutical agent (VRHealth's menopause treatment). While challenges remain in supporting consumer adoption, clients should expect this trend to continue and look to adopt digital therapeutic agents to complement their offerings as a way to engage in a healthcare space previously monopolized by pharma.

For the original news article, click here .


Further Reading

Proteus lends digital therapeutic applications to oncology

News Commentary | January 22, 2019

Proteus Digital Health has unveiled plans to partner with Fairview Health Services to utilize its smart pill technology in its oral oncology treatments. The oral treatments will be augmented with the smart pill technology to allow for monitoring of treatment adherence, giving physicians the ... Not part of subscription

Replacement digital therapeutics offer more opportunities than augmentation therapeutics

Analyst Insight | May 10, 2019

Defining Digital Therapeutics "Digital therapeutics" is a term with many different definitions, making an understanding of the space challenging. At Lux, we are using the definition provided by the Digital Therapeutics Alliance: digital therapeutics are products that deliver therapeutic agents ... Not part of subscription

Sanofi partners with digital therapeutic Happify Health to bring mental health solutions to Multiple Sclerosis patients

News Commentary | September 26, 2019

Biopharmaceutical company Sanofi has signed a deal with mental health platform Happify, in order to support the mental health concerns of individuals living with multiple sclerosis (MS).  Anxiety and depression are two common comorbidities for this degenerative disease, and by providing a treatment ... To read more, click here.